Lundbeck
HLUN-B.CO
#2420
Rank
โ‚น512.18 B
Marketcap
โ‚น536.61
Share price
-0.04%
Change (1 day)
31.70%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): โ‚น38.99 Billion

According to Lundbeck 's latest financial reports the company's current earnings are โ‚น2.98 Billion. In 2023 the company made an earning of โ‚น37.30 Billion, an increase over its 2022 earnings that were of โ‚น30.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น38.99 B4.52%
2023 โ‚น37.30 B21.69%
2022 โ‚น30.65 B31.79%
2021 โ‚น23.26 B-4.53%
2020 โ‚น24.36 B-45.08%
2019 โ‚น44.35 B-33.97%
2018 โ‚น67.17 B12.76%
2017 โ‚น59.57 B94.32%
2016 โ‚น30.66 B-136.98%
2015 -โ‚น82.92 Billion-1258.1%
2014 โ‚น7.15 B-72.43%
2013 โ‚น25.96 B4.31%
2012 โ‚น24.89 B-55.26%
2011 โ‚น55.64 B6.64%
2010 โ‚น52.17 B-6.68%
2009 โ‚น55.91 B